LigaSure™ technology has been used in more than 4 million procedures worldwide.

There are well over 200 published peer-reviewed studies on LigaSure™ technology.

TissueFect™ sensing technology monitors changes in tissue impedance 3,333 times a second, and adjusts energy output accordingly to deliver the appropriate amount of energy for the desired tissue effect.

Valleylab™ mode is responsive energy that helps surgeons manage the tissue effect of surgical devices.

LigaSure™ technology can fuse vessels, including pulmonary vasculature*, up to and including 7 mm, lymphatics and tissue bundles with an average seal cycle of two to four seconds* (*when used with the ForceTriad™ energy platform).

Covidien: Leader in the Medical Device Industry

For more than 40 years, the energy-based devices global business unit of Covidien has led the medical device industry in developing and manufacturing advanced, state-of the-art energy-based surgical systems and devices that help physicians better serve the healthcare needs of patients worldwide.

Founded as Valleylab in 1967 as a medical products distributor, the company soon expanded into product development by designing, manufacturing and marketing advanced electrosurgery systems and accessories. Covidien’s ongoing research and product development continues to bring to market healthcare solutions that enhance safety in the O.R. for both the patient and surgical staff.